Cargando…
An Integrated Strategy for Implementation of Dried Blood Spots in Clinical Development Programs
Dried blood spot (DBS) sample collection has gained increased interest across the pharmaceutical industry as a potential alternative to plasma for pharmacokinetic (PK) evaluations. However, regulatory guidelines and examples of late-stage clinical trial applications in the literature are lacking. Th...
Autores principales: | Kothare, Prajakti A., Bateman, Kevin P., Dockendorf, Marissa, Stone, Julie, Xu, Yang, Woolf, Eric, Shipley, Lisa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779096/ https://www.ncbi.nlm.nih.gov/pubmed/26857396 http://dx.doi.org/10.1208/s12248-015-9860-3 |
Ejemplares similares
-
Leveraging Digital Health Technologies and Outpatient Sampling in Clinical Drug Development: A Phase I Exploratory Study
por: Dockendorf, Marissa F., et al.
Publicado: (2018) -
Digitally Enabled, Patient‐Centric Clinical Trials: Shifting the Drug Development Paradigm
por: Dockendorf, Marissa F., et al.
Publicado: (2020) -
Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies
por: Wong, Marcus P., et al.
Publicado: (2022) -
Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips
por: Drolet, Jeremy, et al.
Publicado: (2017) -
Multi-mycotoxin analysis using dried blood spots and dried serum spots
por: Osteresch, Bernd, et al.
Publicado: (2017)